A Phase I/II, randomized study evaluating the PK/PD of IM administration of ibalizumab patients with HIV-1 infection.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 24 Jul 2017
At a glance
- Drugs Ibalizumab (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics; Pharmacokinetics
- 24 Jul 2017 According to a Theratechnologies media release, results from this study are presented at the 9th IAS Conference on HIV Science 2017.
- 24 Jul 2017 Results published in the Theratechnologies media release.
- 17 Feb 2017 New trial record